us2.ai: Revolutionizing Cardiac Care with AI-Powered Echocardiogram Analysis

us2.ai is a cutting-edge AI ultrasound software platform that transforms echocardiogram interpretation by delivering expert-level accuracy with zero clicks through its real-time AI echo copilot, Echo Copilot™. Designed to democratize echocardiography via augmented intelligence, it automates over 45 key echo parameters—including strain analysis—and is validated for cardiac amyloidosis detection with FDA and CE clearance. The platform seamlessly integrates with any ultrasound device, from GE Vivid CARTs to EchoNous Kosmos mobile systems, empowering clinicians and novices alike to perform reliable heart failure screenings using AI Point-of-Care ultrasound. Backed by peer-reviewed research in journals like The Lancet Digital Health and Nature Communications, and recognized with a FedEx Award, us2.ai brings precision, accessibility, and speed to cardiac diagnostics.

Key Features:

• Real-time AI echo copilot (Echo Copilot™)
• Automation of over 45 echocardiogram parameters, including strain analysis
• FDA-cleared and CE-marked for cardiac amyloidosis detection
• Expert-level interpretation with zero manual input required
• Universal compatibility with any ultrasound device (including GE Vivid CARTs and EchoNous Kosmos)
• Enables heart failure screening via AI Point-of-Care ultrasound
• Validated in high-impact peer-reviewed journals (The Lancet Digital Health, Nature Communications)
• Award-winning technology (FedEx Award)
• Democratizes echocardiography through augmented intelligence

Pricing: us2.ai offers a Freemium model with free access to basic features and premium capabilities available through subscription plans.

Conclusion: us2.ai is a transformative, clinically validated AI tool that brings expert-level echocardiogram analysis to any healthcare provider, making advanced cardiac diagnostics faster, more accessible, and universally available.